Global Genital Herpes Treatment Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

  • receipt Report ID : 147903
  • calendar_today Published On: Apr, 2019
  • file_copy Pages: 128
  • list Pharmaceuticals and Healthcare

The genital herpes treatment includes the use of drug types like Acyclovir that can treat herpes virus infections, including shingles. This medication does not cure herpes, but may prevent herpes sores or blisters. It is also used to treat outbreaks of genital herpes. In people with frequent outbreaks, acyclovir is used to help reduce the number of future episodes. Zovirax is the main brand available in the market for genital herpes. It can also treat chickenpox.

Scope of the Report:

This report focuses on the Genital Herpes Treatment in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Among these drug types prevalent in the genital herpes treatment, Acyclovir segment dominated the global genital herpes treatment market in revenue terms in 2017, and the trend is projected to continue throughout the forecast period.

The worldwide market for Genital Herpes Treatment is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.

Market Segment by Manufacturers, this report covers

Teva

Abbott

Sun

Mylan

Pfizer

GlaxoSmithKline

Dr. Reddy's

Novartis

Valeant

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia etc.)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Acyclovir

Valacyclovir

Famciclovir

Market Segment by Applications, can be divided into

HSV-1

HSV-2

There are 15 Chapters to deeply display the global Genital Herpes Treatment market.

Chapter 1, to describe Genital Herpes Treatment Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Genital Herpes Treatment, with sales, revenue, and price of Genital Herpes Treatment, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Genital Herpes Treatment, for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, Genital Herpes Treatment market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe Genital Herpes Treatment sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

Table of Contents

1 Market Overview

1.1 Genital Herpes Treatment Introduction

1.2 Market Analysis by Type

1.2.1 Acyclovir

1.2.2 Valacyclovir

1.2.3 Famciclovir

1.3 Market Analysis by Applications

1.3.1 HSV-1

1.3.2 HSV-2

1.4 Market Analysis by Regions

1.4.1 North America (United States, Canada and Mexico)

1.4.1.1 United States Market States and Outlook (2013-2023)

1.4.1.2 Canada Market States and Outlook (2013-2023)

1.4.1.3 Mexico Market States and Outlook (2013-2023)

1.4.2 Europe (Germany, France, UK, Russia and Italy)

1.4.2.1 Germany Market States and Outlook (2013-2023)

1.4.2.2 France Market States and Outlook (2013-2023)

1.4.2.3 UK Market States and Outlook (2013-2023)

1.4.2.4 Russia Market States and Outlook (2013-2023)

1.4.2.5 Italy Market States and Outlook (2013-2023)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

1.4.3.1 China Market States and Outlook (2013-2023)

1.4.3.2 Japan Market States and Outlook (2013-2023)

1.4.3.3 Korea Market States and Outlook (2013-2023)

1.4.3.4 India Market States and Outlook (2013-2023)

1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)

1.4.4 South America, Middle East and Africa

1.4.4.1 Brazil Market States and Outlook (2013-2023)

1.4.4.2 Egypt Market States and Outlook (2013-2023)

1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)

1.4.4.4 South Africa Market States and Outlook (2013-2023)

1.4.4.5 Nigeria Market States and Outlook (2013-2023)

1.5 Market Dynamics

1.5.1 Market Opportunities

1.5.2 Market Risk

1.5.3 Market Driving Force

2 Manufacturers Profiles

2.1 Teva

2.1.1 Business Overview

2.1.2 Genital Herpes Treatment Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 Teva Genital Herpes Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.2 Abbott

2.2.1 Business Overview

2.2.2 Genital Herpes Treatment Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 Abbott Genital Herpes Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.3 Sun

2.3.1 Business Overview

2.3.2 Genital Herpes Treatment Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 Sun Genital Herpes Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.4 Mylan

2.4.1 Business Overview

2.4.2 Genital Herpes Treatment Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 Mylan Genital Herpes Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.5 Pfizer

2.5.1 Business Overview

2.5.2 Genital Herpes Treatment Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 Pfizer Genital Herpes Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.6 GlaxoSmithKline

2.6.1 Business Overview

2.6.2 Genital Herpes Treatment Type and Applications

2.6.2.1 Product A

2.6.2.2 Product B

2.6.3 GlaxoSmithKline Genital Herpes Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.7 Dr. Reddy's

2.7.1 Business Overview

2.7.2 Genital Herpes Treatment Type and Applications

2.7.2.1 Product A

2.7.2.2 Product B

2.7.3 Dr. Reddy's Genital Herpes Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.8 Novartis

2.8.1 Business Overview

2.8.2 Genital Herpes Treatment Type and Applications

2.8.2.1 Product A

2.8.2.2 Product B

2.8.3 Novartis Genital Herpes Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.9 Valeant

2.9.1 Business Overview

2.9.2 Genital Herpes Treatment Type and Applications

2.9.2.1 Product A

2.9.2.2 Product B

2.9.3 Valeant Genital Herpes Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

3 Global Genital Herpes Treatment Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)

3.1 Global Genital Herpes Treatment Sales and Market Share by Manufacturer (2016-2017)

3.2 Global Genital Herpes Treatment Revenue and Market Share by Manufacturer (2016-2017)

3.3 Market Concentration Rate

3.3.1 Top 3 Genital Herpes Treatment Manufacturer Market Share in 2017

3.3.2 Top 6 Genital Herpes Treatment Manufacturer Market Share in 2017

3.4 Market Competition Trend

4 Global Genital Herpes Treatment Market Analysis by Regions

4.1 Global Genital Herpes Treatment Sales, Revenue and Market Share by Regions

4.1.1 Global Genital Herpes Treatment Sales and Market Share by Regions (2013-2018)

4.1.2 Global Genital Herpes Treatment Revenue and Market Share by Regions (2013-2018)

4.2 North America Genital Herpes Treatment Sales and Growth Rate (2013-2018)

4.3 Europe Genital Herpes Treatment Sales and Growth Rate (2013-2018)

4.4 Asia-Pacific Genital Herpes Treatment Sales and Growth Rate (2013-2018)

4.5 South America Genital Herpes Treatment Sales and Growth Rate (2013-2018)

4.6 Middle East and Africa Genital Herpes Treatment Sales and Growth Rate (2013-2018)

5 North America Genital Herpes Treatment by Countries

5.1 North America Genital Herpes Treatment Sales, Revenue and Market Share by Countries

5.1.1 North America Genital Herpes Treatment Sales and Market Share by Countries (2013-2018)

5.1.2 North America Genital Herpes Treatment Revenue and Market Share by Countries (2013-2018)

5.2 United States Genital Herpes Treatment Sales and Growth Rate (2013-2018)

5.3 Canada Genital Herpes Treatment Sales and Growth Rate (2013-2018)

5.4 Mexico Genital Herpes Treatment Sales and Growth Rate (2013-2018)

6 Europe Genital Herpes Treatment by Countries

6.1 Europe Genital Herpes Treatment Sales, Revenue and Market Share by Countries

6.1.1 Europe Genital Herpes Treatment Sales and Market Share by Countries (2013-2018)

6.1.2 Europe Genital Herpes Treatment Revenue and Market Share by Countries (2013-2018)

6.2 Germany Genital Herpes Treatment Sales and Growth Rate (2013-2018)

6.3 UK Genital Herpes Treatment Sales and Growth Rate (2013-2018)

6.4 France Genital Herpes Treatment Sales and Growth Rate (2013-2018)

6.5 Russia Genital Herpes Treatment Sales and Growth Rate (2013-2018)

6.6 Italy Genital Herpes Treatment Sales and Growth Rate (2013-2018)

7 Asia-Pacific Genital Herpes Treatment by Countries

7.1 Asia-Pacific Genital Herpes Treatment Sales, Revenue and Market Share by Countries

7.1.1 Asia-Pacific Genital Herpes Treatment Sales and Market Share by Countries (2013-2018)

7.1.2 Asia-Pacific Genital Herpes Treatment Revenue and Market Share by Countries (2013-2018)

7.2 China Genital Herpes Treatment Sales and Growth Rate (2013-2018)

7.3 Japan Genital Herpes Treatment Sales and Growth Rate (2013-2018)

7.4 Korea Genital Herpes Treatment Sales and Growth Rate (2013-2018)

7.5 India Genital Herpes Treatment Sales and Growth Rate (2013-2018)

7.6 Southeast Asia Genital Herpes Treatment Sales and Growth Rate (2013-2018)

8 South America Genital Herpes Treatment by Countries

8.1 South America Genital Herpes Treatment Sales, Revenue and Market Share by Countries

8.1.1 South America Genital Herpes Treatment Sales and Market Share by Countries (2013-2018)

8.1.2 South America Genital Herpes Treatment Revenue and Market Share by Countries (2013-2018)

8.2 Brazil Genital Herpes Treatment Sales and Growth Rate (2013-2018)

8.3 Argentina Genital Herpes Treatment Sales and Growth Rate (2013-2018)

8.4 Colombia Genital Herpes Treatment Sales and Growth Rate (2013-2018)

9 Middle East and Africa Genital Herpes Treatment by Countries

9.1 Middle East and Africa Genital Herpes Treatment Sales, Revenue and Market Share by Countries

9.1.1 Middle East and Africa Genital Herpes Treatment Sales and Market Share by Countries (2013-2018)

9.1.2 Middle East and Africa Genital Herpes Treatment Revenue and Market Share by Countries (2013-2018)

9.2 Saudi Arabia Genital Herpes Treatment Sales and Growth Rate (2013-2018)

9.3 UAE Genital Herpes Treatment Sales and Growth Rate (2013-2018)

9.4 Egypt Genital Herpes Treatment Sales and Growth Rate (2013-2018)

9.5 Nigeria Genital Herpes Treatment Sales and Growth Rate (2013-2018)

9.6 South Africa Genital Herpes Treatment Sales and Growth Rate (2013-2018)

10 Global Genital Herpes Treatment Market Segment by Type

10.1 Global Genital Herpes Treatment Sales, Revenue and Market Share by Type (2013-2018)

10.1.1 Global Genital Herpes Treatment Sales and Market Share by Type (2013-2018)

10.1.2 Global Genital Herpes Treatment Revenue and Market Share by Type (2013-2018)

10.2 Acyclovir Sales Growth and Price

10.2.1 Global Acyclovir Sales Growth (2013-2018)

10.2.2 Global Acyclovir Price (2013-2018)

10.3 Valacyclovir Sales Growth and Price

10.3.1 Global Valacyclovir Sales Growth (2013-2018)

10.3.2 Global Valacyclovir Price (2013-2018)

10.4 Famciclovir Sales Growth and Price

10.4.1 Global Famciclovir Sales Growth (2013-2018)

10.4.2 Global Famciclovir Price (2013-2018)

11 Global Genital Herpes Treatment Market Segment by Application

11.1 Global Genital Herpes Treatment Sales Market Share by Application (2013-2018)

11.2 HSV-1 Sales Growth (2013-2018)

11.3 HSV-2 Sales Growth (2013-2018)

12 Genital Herpes Treatment Market Forecast (2018-2023)

12.1 Global Genital Herpes Treatment Sales, Revenue and Growth Rate (2018-2023)

12.2 Genital Herpes Treatment Market Forecast by Regions (2018-2023)

12.2.1 North America Genital Herpes Treatment Market Forecast (2018-2023)

12.2.2 Europe Genital Herpes Treatment Market Forecast (2018-2023)

12.2.3 Asia-Pacific Genital Herpes Treatment Market Forecast (2018-2023)

12.2.4 South America Genital Herpes Treatment Market Forecast (2018-2023)

12.2.5 Middle East and Africa Genital Herpes Treatment Market Forecast (2018-2023)

12.3 Genital Herpes Treatment Market Forecast by Type (2018-2023)

12.3.1 Global Genital Herpes Treatment Sales Forecast by Type (2018-2023)

12.3.2 Global Genital Herpes Treatment Market Share Forecast by Type (2018-2023)

12.4 Genital Herpes Treatment Market Forecast by Application (2018-2023)

12.4.1 Global Genital Herpes Treatment Sales Forecast by Application (2018-2023)

12.4.2 Global Genital Herpes Treatment Market Share Forecast by Application (2018-2023)

13 Sales Channel, Distributors, Traders and Dealers

13.1 Sales Channel

13.1.1 Direct Marketing

13.1.2 Indirect Marketing

13.1.3 Marketing Channel Future Trend

13.2 Distributors, Traders and Dealers

14 Research Findings and Conclusion

15 Appendix

15.1 Methodology

15.2 Data Source

List of Tables and Figures

Figure Genital Herpes Treatment Picture

Table Product Specifications of Genital Herpes Treatment

Figure Global Sales Market Share of Genital Herpes Treatment by Types in 20

Please fill the form below, to recieve the report sample


+1

Choose License Type

Reach Us

Email us at

sales@mrinsights.biz

Or call us on

US +1-201-465-4211

IND +91-906-779-0957

Why Choose Us

ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems

Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system

Global Outreach6 Major regions and 40+ countries level analysis accomplished

Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery